Innovation
2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace steady.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
Social engagement
Social engagement: 3.6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Claris Ventures, Sunstone.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Angel & family office | 2 | 33% |
| Other / undisclosed | 2 | 33% |
Recent activity
29 Jun 2026
Milestone
regulatory
16 Jun 2026
Event
BIO International Convention 2026
5 May 2026
Event
TIDES USA 2026: Oligonucleotide & Peptide Therapeutics